Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease

British Journal of Haematology

Volumn 158, Issue 6, 2012, Pages 749-762

  Ngoma, Twalib ^a   Adde, Melissa ^b   Durosinmi, Muheez ^c   Githang'a, Jessie ^d   Aken'Ova, Yetunde ^e   Kaijage, Jane ^a   Adeodou, Oluwagbemiga ^c   Rajab, Jamilla ^d   Brown, Biobele J ^e   Leoncini, Lorenzo ^f   Naresh, Kikkeri ^g   Raphael, Martine ^h   Hurwitz, Nina ^b,i   Scanlan, Patricia ^b   Rohatiner, Ama ^b   Venzon, David ^j   Magrath, Ian ^b,k  

^a Ocean Road Cancer Institute ^*  (Tanzania)

^b INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^c OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

^d KENYATTA NATIONAL HOSPITAL   (Kenya)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f UNIVERSITY OF SIENA   (Italy)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

^j NATIONAL CANCER INSTITUTE   (United States)

^k UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

more..

Author keywords

Chemotherapy; Childhood haematological malignancies; Clinical research

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; VINCRISTINE;

ABDOMINAL DISEASE; ADOLESCENT; ADULT; AFRICA; ARTICLE; BONE MARROW METASTASIS; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CENTRAL NERVOUS SYSTEM METASTASIS; CEREBROSPINAL FLUID ANALYSIS; CHICKENPOX; CHILD; CLINICAL PROTOCOL; CRANIAL NERVE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ORBIT TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; SALVAGE THERAPY; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; KAPLAN-MEIER ESTIMATE; MALE; MESNA; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; REMISSION INDUCTION; RISK; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 84865555760     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09236.x     Document Type: Article

References (42)

1. Adde, M., Shad, A., Venzon, D., Arndt, C., Gootenberg, J., Neely, J., Nieder, M., Owen, W., Seibel, N., Wilson, W., Horak, I.D. & Magrath, I. (1998) Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Seminars in Oncology, 2(Suppl 4), 33-39.
2. Advani, S., Pai, S., Adde, M., Vaidya, S., Vats, T., Naresh, N.K., Venzon, D. & Magrath, I. (1997) Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India. Annals of Oncology, 8, 893-897.
3. Arthur, F.K., Owusu, L., Yeboah, F.A., Rettig, T. & Osei-Akoto, A. (2011) Prognostic significance of biochemical markers in African Burkitt's lymphoma. Clinical and Translational Oncology, 13, 731-736.
4. Booth, K., Burkitt, D.P., Bassett, D.J., Cooke, R.A. & Biddulph, J. (1967) Burkitt lymphoma in Papua New Guinea. British Journal of Cancer, 21, 657-664.
5. Burkitt, D. (1958) A sarcoma involving the jaws in African children. British Journal of Surgery, 46, 218-223.
6. Burkitt, D. (1962) A children's cancer dependent on climatic factors. Nature, 194, 232-234.
7. Burkitt, D. (1967a) Long-term remissions following one and two-dose chemotherapy for African lymphoma. Cancer, 20, 756-759.
8. Burkitt, D. (1967b) Chemotherapy of jaw tumours. In: Treatment of Burkitt's Tumour. Monograph Series Number 8, International Union Against Cancer (ed. by J.H. Burchenal & D.P. Burkitt), pp. 94-104. Springer, New York.
9. Clifford, P., Singh, S., Stjernswärd, J. & Klein, G. (1967) Long term survival of patients with Burkitt's lymphoma. An assessment of treatment and other factors which may relate to survival. Cancer Research, 27, 2578-2615.
10. Dalldorf, G., Linsell, C.A., Barnhart, F.E. & Martyn, R. (1964) An epidemiological approach to the lymphomas of African children and Burkitt's sarcoma of the jaws. Perspectives in Biological Medicine, 7, 435-449.
11. Gad-el-Mawla, N., Hussein, M.H., Abdel-Hadi, S., el-Taneer, O., Adde, M. & Magrath, I.T. (1989) Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen. Cancer Chemotherapy and Pharmacology, 24(Suppl 1), S20-S23.
12. Haddy, T.B., Adde, M.A. & Magrath, I.T. (1991) CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? Journal of Clinical Oncology, 9, 1973-1982.
13. Hesseling, P.B., Broadhead, R., Molyneux, E., Borgstein, E., Schneider, J.W., Louw, M., Mansvelt, E.P. & Wessels, G. (2003) Malawi pilot study of Burkitt lymphoma treatment. Medical and Pediatric Oncology, 41, 532-540.
14. Hesseling, P., Molyneux, E., Kamiza, S., Israels, T. & Broadhead, R. (2009) Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Annals of Tropical Paediatrics, 29, 29-34.
15. Hesseling, P.B., Njume, E., Kouya, F., Katayi, T., Wharin, P., Tamannai, M., Achu, P., Kidd, M. & McCormick, P. (2012) The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy. Pediatric Hematology Oncology, 9, 119-129.
16. Kazembe, P., Hesseling, P.B., Griffin, B.E., Lampert, I. & Wessels, G. (2003) Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Medical and Pediatric Oncology, 40, 23-25.
17. Koffi, G.K., Tolo, A., Nanho, D.C., N'dathz, E., Kouassi, M.Y., N'Diaye, F.D., Kouakou, B., Meité, N., Ayemou, R., Sekongo, M., Kouehion, P., Meité, M., Tea, N.D., Sangaré, A. & Sanogo, I. (2010) Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharan Africa: experience of Côte d'Ivoire. International Journal of Hematology, 91, 838-843.
18. Magrath, I.T. (1991) African Burkitt's lymphoma. History, biology, clinical features, and treatment. American Journal of Pediatric Hematology Oncology, 13, 222-246.
19. Magrath, I. (2009) Lessons from clinical trials in African Burkitt lymphoma. Current Opinions in Oncology, 21, 462-468.
20. Magrath, I. (2012) Towards curative therapy in Burkitt lymphoma: the role of early African studies in demonstrating the value of combination therapy and CNS prophylaxis. Advances in Hematology, 2012, Article ID 13068. doi:10.1155/2012/130680.
21. Magrath, I.T., Lwanga, S., Carswell, W. & Harrison, N. (1974) Surgical reduction of tumour bulk in the management of abdominal Burkitt's lymphoma. British Medical Journal, 2, 308-312.
22. Magrath, I., Lee, Y.J., Anderson, T., Henle, W., Ziegler, J., Simon, R. & Schein, P. (1980) Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer, 45, 1507-1515.
23. Magrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N., Gootenberg, J., Neely, J., Arndt, C., Nieder, M., Jaffe, E., Wittes, R.A. & Horak, I.D. (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. Journal of Clinical Oncology, 14, 925-934.
24. Magrath, I., Shanta, V., Advani, S., Adde, M., Arya, L.S., Banavali, S., Bhargava, M., Bhatia, K., Gutiérrez, M., Liewehr, D., Pai, S., Sagar, T.G., Venzon, D. & Raina, V. (2005) Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. European Journal of Cancer, 41, 1570-1583. doi:10.1155/2012/130680 Erratum in: European Journal of Cancer. 2007 February;43(3):632. Raina, V [added].
25. Marjerrison, S., Fernandez, C.V., Price, V.E., Njume, E. & Hesseling, P. (2012) The use of ultrasound in endemic Burkitt lymphoma in Cameroon. Pediatric Blood Cancer, 58, 352-355.
26. Meremikwu, M.M., Ehiri, J.E., Nkanga, D.G., Udoh, E.E., Ikpatt, O.F. & Alaje, E.O. (2005) Socioeconomic constraints to effective management of Burkitt's lymphoma in south-eastern Nigeria. Tropical Medicine International Health, 10, 92-98.
27. Morrow, R.H., Kisuule, A., Pike, M.C. & Smith, P.G. (1976) Burkitt's lymphoma in the Mengo districts of Uganda; epidemiological features and their relationship to Malaria. Journal of the National Cancer Institute, 56, 479-483.
28. Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332-339.
29. Naresh, K.N., Raphael, M., Ayers, L., Hurwitz, N., Calbi, V., Rogena, E., Sayed, S., Sherman, O., Ibrahim, H.A., Lazzi, S., Mourmouras, V., Rince, P., Githang'a, J., Byakika, B., Moshi, E., Durosinmi, M., Olasode, B.J., Oluwasola, O.A., Akang, E.E., Aken'Ova, Y., Adde, M., Magrath, I. & Leoncini, L. (2011a) Lymphomas in sub-Saharan Africa - what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? British Journal of Haematology, 154, 696-703.
30. Naresh, K.N., Ibrahim, H.A., Lazzi, S., Rince, P., Onorati, M., Ambrosio, M.R., Bilhou-Nabera, C., Amen, F., Reid, A., Mawanda, M., Calbi, V., Ogwang, M., Rogena, E., Byakika, B., Sayed, S., Moshi, E., Mwakigonja, A., Raphael, M., Magrath, I. & Leoncini, L. (2011b) Diagnosis of Burkitt lymphoma using an algorithmic approach - applicable in both resource-poor and resource-rich countries. British Journal of Haematology, 154, 770-776.
31. Ngu, V.A. (1965) The African lymphoma (Burkitt tumour) survivals exceeding two years. British Journal of Cancer, 19, 101-107.
32. Olweny, C.L., Katongole-Mbidde, E., Kaddu-Mukasa, A., Atine, I., Owor, R., Lwanga, S., Carswell, W. & Magrath, I.T. (1976) Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy. International Journal of Cancer, 17, 436-440.
33. Olweny, C.L., Atine, I., Kaddu-Mukasa, A., Katongole-Mbidde, E., Lwanga, S.K., Johansson, B., Onyango, J., Host, H., Norin, T. & Willey, B. (1977) Cerebrospinal irradiation of Burkitt's lymphoma. Failure in preventing central nervous system relapse. Acta Radiologica Therapeutica Physics Biology, 16, 225-231.
34. Olweny, C.L., Katongole-Mbidde, E., Otim, D., Lwanga, S.K., Magrath, I.T. & Ziegler, J.L. (1980) Long-term experience with Burkitt's lymphoma in Uganda. International Journal of Cancer, 26, 261-266.
35. Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G., Frappaz, D., Lutz, P., Coze, C., Perel, Y., Raphaël, M. & Terrier-Lacombe, M.J. on behalf of the Société Française d'Oncologie Pédiatrique. (2001) The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 97, 3370-3379.
36. Rainey, J.J., Mwanda, W.O., Wairiumu, P., Moormann, A.M., Wilson, M.L. & Rochford, R. (2007) Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Tropical Medicine and International Health, 12, 936-943.
37. Traoré, F., Coze, C., Atteby, J.J., André, N., Moreira, C., Doumbe, P., Ravelomanana, N., Ye, D., Patte, C., Raquin, M.A., Raphaël, M. & Lemerle, J. (2011) Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatric Blood Cancer, 56, 70-76.
38. Wright, D.H. (1970) Gross distribution and haematology. In: Burkitt's Tumour (ed. by P.D. Burkitt & D.H. Wright), pp. 64-81. E. & S. Livingstone, Edinburgh and London.
39. Ziegler, J.L. (1972) Chemotherapy of Burkitt's lymphoma. Cancer, 30, 1534-1540.
40. Ziegler, J.L. & Bluming, A.Z. (1971) Intrathecal chemotherapy in Burkitt's lymphoma. British Medical Journal, 3, 508-512.
41. Ziegler, J.L., Bluming, A.Z., Fass, L. & Morrow, R.H. (1972) Relapse patterns in Burkitt's lymphoma. Cancer Research, 32, 1267-1272.
42. Ziegler, J.L., Magrath, I.T. & Olweny, C.L.M. (1979) Cure of Burkitt's lymphoma: ten-year follow-up of 157 Ugandan patients. Lancet, ii, 936-938.